Abstract
Objective: to evaluate the safety of long-term use of Urisan. Subjects and methods. The safety of long-term (6-month) use of Urisan in 30 patients with the significant diagnosis of gout was studied. Results. Urisan was generally well tolerated. The findings suggest the drug has neither nephro- and hepatotoxicity nor negative effect on carbohydrate and lipid metabolism. Conclusion. The herbal complex Urisan has proved to be an effective and safe agent for long-term therapy in patients with gout.
Highlights
Objective: to evaluate the safety of long-term use of Urisan
The findings suggest the drug has neither nephro- and hepatotoxicity nor negative effect on carbohydrate and lipid metabolism
Приложения, включенные в атлас, содержат карты обследования пациентов
Summary
Целью настоящего исследования явилась оценка безопасности длительного назначения Урисана. Проведено исследование безопасности длительного (6 мес) применения Урисана у 30 больных с достоверным диагнозом подагры. Полученные данные свидетельствуют об отсутствии у Урисана нефро- и гепатотоксичности, негативного влияния на углеводный и липидный обмен. Растительный комплекс Урисан зарекомендовал себя как эффективное и безопасное средство для длительной терапии больных подагрой
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
